NASENSPRAYVORRICHTUNG

European patent · EP2926855 · Deleted

Register entry

Publication number
EP2926855
Application number
EP15164095
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 12, 2011
Published
Oct 7, 2015
Granted
Dec 5, 2018
Deleted
May 27, 2026
Reason
Annual fee unpaid
IPC classes
A61M 15/08 (2006.01)
Priority
US 392223 P 12.10.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 27, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    27.05.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 27.05.2026

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Mar 6, 2019

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 06.03.2019

  6. Dec 5, 2018

    Granted

    Published in Swissreg on 05.12.2018

Parties

Holder

Teva Branded Pharmaceutical Products R & D, Inc.

425 Privet Rd, Horsham, PA 19044, US

Ivax Pharmaceuticals Ireland

Unit 301 Industrial Park, Waterford, IE

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

Walsh, Declan

Co.Kilkenny, IE

Zeng, Xian-Ming

Miami, FL 33169-5043, US

Ly, Jade

Miami, FL 33169-5043, US

Morales, Armando

Miami, FL 33169-5043, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.